Marilyn E. Thompson

1.9k total citations
23 papers, 1.6k citations indexed

About

Marilyn E. Thompson is a scholar working on Molecular Biology, Genetics and Reproductive Medicine. According to data from OpenAlex, Marilyn E. Thompson has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Reproductive Medicine. Recurrent topics in Marilyn E. Thompson's work include BRCA gene mutations in cancer (6 papers), DNA Repair Mechanisms (5 papers) and CRISPR and Genetic Engineering (5 papers). Marilyn E. Thompson is often cited by papers focused on BRCA gene mutations in cancer (6 papers), DNA Repair Mechanisms (5 papers) and CRISPR and Genetic Engineering (5 papers). Marilyn E. Thompson collaborates with scholars based in United States, Canada and Ukraine. Marilyn E. Thompson's co-authors include Jeffrey T. Holt, David L. Page, Patrice S. Obermiller, Roy A. Jensen, Cheryl Robinson‐Benion, Csilla I. Szabo, Mary‐Claire King, Carlos L. Arteaga, Derek W. Abbott and Gail E. Tomlinson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Endocrinology.

In The Last Decade

Marilyn E. Thompson

23 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn E. Thompson United States 15 1.1k 818 247 204 146 23 1.6k
Caroline J. Speed Australia 17 655 0.6× 669 0.8× 231 0.9× 77 0.4× 64 0.4× 22 1.5k
Larry N. Petz United States 13 614 0.5× 814 1.0× 287 1.2× 146 0.7× 70 0.5× 13 1.2k
Johanna Tommiska Finland 25 1.3k 1.2× 560 0.7× 590 2.4× 336 1.6× 130 0.9× 39 1.9k
Guillermo P. Vicent Spain 25 1.5k 1.4× 547 0.7× 325 1.3× 211 1.0× 31 0.2× 53 2.0k
Catharine L. Smith United States 21 814 0.7× 488 0.6× 174 0.7× 138 0.7× 53 0.4× 39 1.2k
Srikanth Jammulapati United States 6 598 0.5× 331 0.4× 445 1.8× 251 1.2× 82 0.6× 8 1.1k
Ulla Karvonen Finland 18 1.6k 1.4× 646 0.8× 427 1.7× 223 1.1× 43 0.3× 33 2.1k
Bettina Hanstein Germany 17 635 0.6× 654 0.8× 283 1.1× 129 0.6× 89 0.6× 30 1.2k
Joyce C. Wu United States 16 905 0.8× 242 0.3× 180 0.7× 129 0.6× 59 0.4× 20 1.5k
Nanda Singh United States 16 1.4k 1.2× 562 0.7× 540 2.2× 410 2.0× 464 3.2× 21 2.4k

Countries citing papers authored by Marilyn E. Thompson

Since Specialization
Citations

This map shows the geographic impact of Marilyn E. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn E. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn E. Thompson more than expected).

Fields of papers citing papers by Marilyn E. Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn E. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn E. Thompson. The network helps show where Marilyn E. Thompson may publish in the future.

Co-authorship network of co-authors of Marilyn E. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn E. Thompson. A scholar is included among the top collaborators of Marilyn E. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn E. Thompson. Marilyn E. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hahn, Lindsay, et al.. (2019). An innovative escape room activity to assess student readiness for advanced pharmacy practice experiences (APPEs). Currents in Pharmacy Teaching and Learning. 11(7). 723–728. 81 indexed citations
2.
Thompson, Marilyn E.. (2010). BRCA1 16 years later: an overview. FEBS Journal. 277(15). 3071–3071. 2 indexed citations
3.
Thompson, Marilyn E.. (2010). BRCA1 16 years later: nuclear import and export processes. FEBS Journal. 277(15). 3072–3078. 53 indexed citations
4.
Thompson, Marilyn E., et al.. (2008). Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent. Cellular Signalling. 20(5). 958–968. 10 indexed citations
5.
Hinton, Cimona V., et al.. (2007). Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1. Experimental Cell Research. 313(9). 1735–1744. 23 indexed citations
6.
Brandt, Stephen J., et al.. (2007). BRCA1 accumulates in the nucleus in response to hypoxia and TRAIL and enhances TRAIL‐induced apoptosis in breast cancer cells. FEBS Journal. 274(19). 5137–5146. 6 indexed citations
7.
Thompson, Marilyn E., Cheryl Robinson‐Benion, & Jeffrey T. Holt. (2005). An Amino-terminal Motif Functions as a Second Nuclear Export Sequence in BRCA1. Journal of Biological Chemistry. 280(23). 21854–21857. 38 indexed citations
8.
Abbott, Derek W., Marilyn E. Thompson, Cheryl Robinson‐Benion, et al.. (1999). BRCA1 Expression Restores Radiation Resistance in BRCA1-defective Cancer Cells through Enhancement of Transcription-coupled DNA Repair. Journal of Biological Chemistry. 274(26). 18808–18812. 183 indexed citations
9.
Jensen, Roy A., Marilyn E. Thompson, Thomas L. Jetton, et al.. (1996). BRCA1 is secreted and exhibits properties of a granin. Nature Genetics. 12(3). 303–308. 145 indexed citations
10.
Holt, Jeffrey T., Marilyn E. Thompson, Csilla I. Szabo, et al.. (1996). Growth retardation and tumour inhibition by BRCA1. Nature Genetics. 12(3). 298–302. 290 indexed citations
11.
Jensen, Roy A., Marilyn E. Thompson, Thomas L. Jetton, et al.. (1996). Reply to “…and secreted tumour suppressors”. Nature Genetics. 13(3). 269–272. 17 indexed citations
12.
Holt, Jeffrey T., Marilyn E. Thompson, Csilla I. Szabo, et al.. (1996). Growth Retardation and Tumour Inhibition by BRCA1. Obstetrical & Gynecological Survey. 51(7). 411–413. 1 indexed citations
13.
Thompson, Marilyn E., et al.. (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genetics. 9(4). 444–450. 474 indexed citations
14.
Thompson, Marilyn E., Donna L. Valentine, Samuel J. Strada, JA Wagner, & Jonathan G. Scammell. (1994). Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.. Molecular Pharmacology. 46(5). 880–889. 19 indexed citations
15.
Kuske, Cheryl R., et al.. (1994). Purification and characterization of O-acetylserine sulfhydrylase isoenzymes from Datura innoxia.. Journal of Biological Chemistry. 269(8). 6223–6232. 39 indexed citations
16.
Thompson, Marilyn E., Warren E. Zimmer, William J. Thompson, et al.. (1992). Differential regulation of chromogranin B/secretogranin I and secretogranin II by forskolin in PC12 cells. Molecular Brain Research. 12(1-3). 195–202. 35 indexed citations
17.
18.
Thompson, Marilyn E., et al.. (1992). Prolactin granulogenesis is associated with increased secretogranin expression and aggregation in the Golgi apparatus of GH4C1 cells.. Endocrinology. 131(1). 318–326. 29 indexed citations
19.
Lincoln, Thomas, Marilyn E. Thompson, & Trudy L. Cornwell. (1988). Purification and characterization of two forms of cyclic GMP-dependent protein kinase from bovine aorta.. Journal of Biological Chemistry. 263(33). 17632–17637. 73 indexed citations
20.
Spoerl, Edward, R.J. Doyle, & Marilyn E. Thompson. (1965). Limiting factors involved in CO2 production by starved and X‐irradiated starved yeast cells. Journal of Cellular and Comparative Physiology. 65(2). 271–276. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline J. Speed Breakdown of academic impact, for papers by Larry N. Petz Breakdown of academic impact, for papers by Johanna Tommiska Breakdown of academic impact, for papers by Guillermo P. Vicent Breakdown of academic impact, for papers by Catharine L. Smith Breakdown of academic impact, for papers by Srikanth Jammulapati Breakdown of academic impact, for papers by Ulla Karvonen Breakdown of academic impact, for papers by Bettina Hanstein Breakdown of academic impact, for papers by Joyce C. Wu Breakdown of academic impact, for papers by Nanda Singh
Rankless by CCL
2026